Sign up to save your podcasts
Or
Share The Canadian Breakpoint
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Canadian Breakpoint
The Canadian Breakpoint episodes
- Disseminated Gonorrhea Infections
Dr. Rupeena Purewal invites special guest Dr. David Alexander, PhD Microbiologist in Winnipeg, to discuss Disseminated Gonorrhea Infections.
42 min - A Review of Dolutegravir dispersible tab
Dr. Rupeena Purewal invites special guest Dr. Jason Brophy, Infectious Diseases Pediatrician at the Children's Hospital of Eastern Ontario, to review Dolutegravir, an antiretroviral agent for the treatment of HIV.
Canadian Dolutegravir Product Monograph: tivicay.pdf (viivexchange.com)
48 min - Complicated TB Cases
Dr. Rupeena Purewal invites special guest Dr. Mahli Brindamour, Pediatrician with the Saskatchewan TB Prevention and Control program, to discuss Complicated TB cases.
1 hr 1 min - Tuberculosis Guideline Update for Canada
Dr. Rupeena Purewal invites special guest Dr. Rachel Dwilow, Pediatric Infectious Diseases Physician at Children's Hospital Research Institute of Manitoba, to discuss the Tuberculosis Guideline Update for Canada.
43 min - Antimicrobial Stewardship Programs
Dr. Rupeena Purewal welcomes 2 special guests; Pediatric Infectious Diseases Specialist, Dr. Jason Newland in St. Louis as well as Pediatric Infectious Diseases Specialist, Dr. Michelle Mitchell in Milwaukee, to discuss the importance of Antimicrobial Stewardship Programs.
Canadian Antimicrobial Resistance Alliance (CARA): www.can-r.com
Canadian collaborative AMR Awareness campaign: www.antibioticawareness.ca
NCCID: www.nncid.ca
Pan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
48 min - Cytomegalovirus (CMV)
Dr. Rupeena Purewal invites special guest Dr. Ari Bitnun, Professor of Pediatrics at University of Toronto, to discuss CMV in Canada.
41 min - A review of Cabenuva®, an antiretroviral agent for HIV.
Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.
37 min - A review of Baloxavir®, an antiviral treatment for influenza A and B.
Dr. Rupeena Purewal, pediatric infectious disease physician, reviews Balxoavir Marboxil®, an oral antiviral medication for treatment of influenza A and influenza B flu. Baloxavir® was approved for medical use in Canada in 2020.
Canadian Baloxavir Product Monograph : [Product Monograph Template - Standard] (hres.ca)
26 min - Rising Syphilis in Canada
Dr. Rupeena Purewal invites special guest Dr. Ameeta Singh, Infectious Diseases Specialist in Edmonton Alberta, to discuss the rising cases of syphilis in Canada.
39 min - A summary of the Canadian Antimicrobial Resistance Surveillance System 2020 Report.
Dr. Rupeena Purewal, Pediatric Infectious Diseases Physician, summarizes the key findings from the 2020 Canadian Antimicrobial Resistance Surveillance System (CARSS) Report. CARSS is Canada's national system for reporting on antimicrobial use and is one of the Public Health Agency of Canada's commitments as part of the Pan-Canadian framework for action on antimicrobial resistance and antimicrobial use.
Pan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html
36 min
About The Canadian Breakpoint
From the publisher's feed
A Canadian Infectious Diseases Podcast by Canadian Infectious Diseases Physicians.